Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Dopaminergic Neurogenesis WP2855,0.014164541794417061,13.241031390134529,56.36724930164434,"['ALDH1A1', 'GLI1']",0.6539984346091852,0,0,2
2,MED and Pseudoachondroplasia genes WP4789,0.018681360040759185,inf,inf,['COL9A2'],0.6539984346091852,0,0,1
3,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.02515372531141905,5.138622493461203,18.92425823501275,"['CTNNA1', 'MAP4K5', 'TEAD1']",0.6539984346091852,0,0,3
4,Sleep regulation WP3591,0.031089798548592118,8.144877543980684,28.26985619933413,"['ADORA1', 'PTGDS']",0.6539984346091852,0,0,2
5,MAPK pathway in congenital thyroid cancer WP4928,0.031089798548592118,8.144877543980684,28.26985619933413,"['ALK', 'GAREM2']",0.6539984346091852,0,0,2
6,ATM Signaling Network in Development and Disease  WP3878,0.03590856289286987,4.423048048048048,14.714505535000708,"['PRKDC', 'PPM1D', 'HMGN1']",0.6539984346091852,0,0,3
7,Methionine De Novo and Salvage Pathway WP3580,0.039300815290896296,7.057698056801196,22.84231044373022,"['CHDH', 'ODC1']",0.6539984346091852,0,0,2
8,Hippo-Merlin Signaling Dysregulation WP4541,0.041767932399680484,3.2230906348553408,10.235331713980049,"['PDGFRB', 'CTNNA1', 'ITGA7', 'TEAD1']",0.6539984346091852,0,0,4
9,Genes controlling nephrogenesis WP4823,0.043680114062680804,6.61603139013453,20.713883494646502,"['NOTCH2', 'PDGFRB']",0.6539984346091852,0,0,2
10,Osteoblast differentiation WP4787,0.045555445145750495,3.127761511844557,9.661108327945366,"['NOTCH2', 'FZD3', 'PRKDC', 'WNT7A']",0.6539984346091852,0,0,4
11,White fat cell differentiation WP4149,0.048231036658860076,6.2263255077815876,18.87667824197835,"['CTNNA1', 'RORA']",0.6539984346091852,0,0,2
12,Regulation of Actin Cytoskeleton WP51,0.0534264117590732,2.5600961538461537,7.499673813727205,"['PDGFRB', 'MRAS', 'GSN', 'IQGAP1', 'ARHGEF6']",0.6539984346091852,0,0,5
13,Fatty Acid Omega Oxidation WP206,0.05500826663869841,26.377232142857142,76.50114261250998,['ALDH1A1'],0.6539984346091852,0,0,1
14,Hypothetical Craniofacial Development Pathway WP3655,0.05500826663869841,26.377232142857142,76.50114261250998,['ARHGAP29'],0.6539984346091852,0,0,1
15,Rett syndrome causing genes WP4312,0.05723074052259201,3.6164004914004915,10.345307068660254,"['SYNGAP1', 'CDKL5', 'KCNJ10']",0.6539984346091852,0,0,3
16,Wnt signaling in kidney disease WP4150,0.05781647300719401,5.569978758555582,15.877121650532505,"['FZD3', 'WNT7A']",0.6539984346091852,0,0,2
17,Kit receptor signaling pathway WP304,0.060236824757078915,3.5357357357357357,9.933548451393387,"['RPS6KA3', 'INPP5D', 'MAPT']",0.6539984346091852,0,0,3
18,NRF2 pathway WP2884,0.07214206026830022,2.6558823529411764,6.982628218476343,"['SLC6A9', 'FTH1', 'SLC39A11', 'SLC5A3']",0.6539984346091852,0,0,4
19,Somatic sex determination WP4814,0.07266649273435391,17.583333333333332,46.10130029735828,['PTGDS'],0.6539984346091852,0,0,1
20,EDA signaling in hair follicle development WP3930,0.07266649273435391,17.583333333333332,46.10130029735828,['GLI1'],0.6539984346091852,0,0,1
21,Nucleotide GPCRs WP80,0.07266649273435391,17.583333333333332,46.10130029735828,['ADORA1'],0.6539984346091852,0,0,1
22,Osteoblast Signaling WP322,0.07266649273435391,17.583333333333332,46.10130029735828,['PDGFRB'],0.6539984346091852,0,0,1
23,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.07976119935576108,3.1181770005299416,7.884990671330181,"['FZD3', 'H2AFY2', 'WNT7A']",0.6580298946850289,0,0,3
24,Pathways affected in adenoid cystic carcinoma WP3651,0.07976119935576108,3.1181770005299416,7.884990671330181,"['PRKDC', 'UHRF1', 'NFIB']",0.6580298946850289,0,0,3
25,Circadian rhythm related genes WP3594,0.08498231526112582,2.215719696969697,5.462440578903737,"['PRKDC', 'CRY2', 'ADORA1', 'RORA', 'PTGDS']",0.6599721238009653,0,0,5
26,Nephrogenesis WP5052,0.08999619870013163,13.186383928571429,31.752652235446597,['NOTCH2'],0.6599721238009653,0,0,1
27,Role of Osx and miRNAs in tooth development WP3971,0.08999619870013163,13.186383928571429,31.752652235446597,['NOTCH2'],0.6599721238009653,0,0,1
28,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.1070034679771285,10.548214285714286,23.57414117696324,['ALDH1A1'],0.6804900514181625,0,0,1
29,Glucuronidation WP698,0.1070034679771285,10.548214285714286,23.57414117696324,['PGM2'],0.6804900514181625,0,0,1
30,Disruption of postsynaptic signaling by CNV WP4875,0.11972619760802017,3.5243647234678623,7.480632695266695,"['SYNGAP1', 'DLGAP1']",0.6804900514181625,0,0,2
31,Phosphoinositides metabolism WP4971,0.12595067267214766,3.4103862288442066,7.065859643749437,"['INPP5D', 'PLCE1']",0.6804900514181625,0,0,2
32,Iron metabolism in placenta WP2007,0.14007447472522544,7.533163265306122,14.807042851547626,['FTH1'],0.6804900514181625,0,0,1
33,Pathways in clear cell renal cell carcinoma WP4018,0.14265822141110238,2.3703106091165793,4.61571431004451,"['PDGFRB', 'PGM2', 'PFKP']",0.6804900514181625,0,0,3
34,Hedgehog Signaling Pathway WP4249,0.14505647153234508,3.1086784489580586,6.001714568566623,"['GRK3', 'GLI1']",0.6804900514181625,0,0,2
35,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.15065518666672598,1.713507143909265,3.2432604983185183,"['PDGFRB', 'ANGPT1', 'CAB39L', 'COL11A1', 'ITGA7', 'CREB5']",0.6804900514181625,0,0,6
36,PI3K-Akt signaling pathway WP4172,0.15323466906309352,1.7041974946890337,3.1967076679641813,"['PDGFRB', 'ANGPT1', 'ITGA7', 'COL9A2', 'SGK2', 'CREB5']",0.6804900514181625,0,0,6
37,Development and heterogeneity of the ILC family WP3893,0.15614982878851075,6.590959821428571,12.239012262485476,['RORA'],0.6804900514181625,0,0,1
38,Integrin-mediated Cell Adhesion WP185,0.16491989326202913,2.2047672672672673,3.9736419443331927,"['CAPN5', 'CAPN2', 'ITGA7']",0.6804900514181625,0,0,3
39,TCA cycle in senescence WP5050,0.17192598306830564,5.858134920634921,10.314366754231669,['ME2'],0.6804900514181625,0,0,1
40,Eicosanoid Synthesis WP167,0.17192598306830564,5.858134920634921,10.314366754231669,['PTGDS'],0.6804900514181625,0,0,1
41,miR-509-3p alteration of YAP1/ECM axis WP3967,0.17192598306830564,5.858134920634921,10.314366754231669,['TEAD1'],0.6804900514181625,0,0,1
42,Non-homologous end joining WP438,0.17192598306830564,5.858134920634921,10.314366754231669,['PRKDC'],0.6804900514181625,0,0,1
43,Genotoxicity pathway WP4286,0.1780618883815161,2.708980108083247,4.674681365216693,"['PPM1D', 'TOPORS']",0.6804900514181625,0,0,2
44,ESC Pluripotency Pathways WP3931,0.178741609550533,2.116036036036036,3.6434205519451424,"['PDGFRB', 'FZD3', 'WNT7A']",0.6804900514181625,0,0,3
45,GPR40 Pathway WP3958,0.18740848181330888,5.271875,8.82756832527147,['PLCE1'],0.6804900514181625,0,0,1
46,Imatinib and Chronic Myeloid Leukemia WP3640,0.18740848181330888,5.271875,8.82756832527147,['PDGFRB'],0.6804900514181625,0,0,1
47,Mammalian disorder of sexual development WP4842,0.18740848181330888,5.271875,8.82756832527147,['PTGDS'],0.6804900514181625,0,0,1
48,Cori Cycle WP1946,0.2026027669611395,4.792207792207792,7.650798221685978,['PFKP'],0.6804900514181625,0,0,1
49,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.205211474809759,2.4561476692042965,3.8898360567579315,"['FZD3', 'WNT7A']",0.6804900514181625,0,0,2
50,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.20969051604400527,1.7353312068837623,2.7108000419240548,"['RPS6KA3', 'CDKL5', 'KCNN2', 'MAPT']",0.6804900514181625,0,0,4
51,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.2175141801210455,4.392485119047619,6.700697547304754,['NRF1'],0.6804900514181625,0,0,1
52,Hedgehog Signaling Pathway Netpath WP47,0.2175141801210455,4.392485119047619,6.700697547304754,['GLI1'],0.6804900514181625,0,0,1
53,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.21895296382191953,2.3465869456900847,3.5642270383032173,"['CTNNA1', 'ITGA7']",0.6804900514181625,0,0,2
54,DNA damage response WP707,0.22585366681319222,2.2953792162214857,3.4152212409877496,"['PRKDC', 'SESN1']",0.6804900514181625,0,0,2
55,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.2321479643888315,4.054258241758242,5.9207590014564575,['DKK3'],0.6804900514181625,0,0,1
56,Ras signaling WP4223,0.23745667993743438,1.6401838016065102,2.358207183197936,"['PDGFRB', 'SYNGAP1', 'MRAS', 'PLCE1']",0.6804900514181625,0,0,4
57,miRNA regulation of DNA damage response WP1530,0.23969952941652672,2.1993647234678626,3.1415046123079406,"['PRKDC', 'SESN1']",0.6804900514181625,0,0,2
58,Notch Signaling Pathway Netpath WP61,0.23969952941652672,2.1993647234678626,3.1415046123079406,"['NOTCH2', 'MAPT']",0.6804900514181625,0,0,2
59,Triacylglyceride synthesis WP325,0.24650926606468523,3.764349489795918,5.271428248565033,['PLPP1'],0.6804900514181625,0,0,1
60,Constitutive Androstane Receptor Pathway WP2875,0.24650926606468523,3.764349489795918,5.271428248565033,['DNAJC7'],0.6804900514181625,0,0,1
61,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.24650926606468523,3.764349489795918,5.271428248565033,['PTGDS'],0.6804900514181625,0,0,1
62,Pregnane X receptor pathway WP2876,0.24650926606468523,3.764349489795918,5.271428248565033,['DNAJC7'],0.6804900514181625,0,0,1
63,Purinergic signaling WP4900,0.24650926606468523,3.764349489795918,5.271428248565033,['ADORA1'],0.6804900514181625,0,0,1
64,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2567403565666051,1.7416097416097416,2.3680493330285652,"['NOTCH2', 'FZD3', 'WNT7A']",0.6804900514181625,0,0,3
65,Nuclear Receptors Meta-Pathway WP2882,0.25739844723681604,1.486338100102145,2.0171540500624974,"['SLC6A9', 'DNAJC7', 'FTH1', 'SLC39A11', 'SLC5A3']",0.6804900514181625,0,0,5
66,EGF/EGFR signaling pathway WP437,0.25779654838166466,1.5783075572364422,2.1395293828434236,"['RPS6KA3', 'INPP5D', 'PLCE1', 'IQGAP1']",0.6804900514181625,0,0,4
67,Insulin Signaling WP481,0.25779654838166466,1.5783075572364422,2.1395293828434236,"['RPS6KA3', 'MAP4K5', 'SGK2', 'RHOQ']",0.6804900514181625,0,0,4
68,Transcription co-factors SKI and SKIL protein partners WP4533,0.26060313655963313,3.513095238095238,4.724257932143325,['TEAD1'],0.6804900514181625,0,0,1
69,Mitochondrial Gene Expression WP391,0.26060313655963313,3.513095238095238,4.724257932143325,['NRF1'],0.6804900514181625,0,0,1
70,MAPK Signaling Pathway WP382,0.26448521149859205,1.4695707070707071,1.9544848657042209,"['PDGFRB', 'RPS6KA3', 'MRAS', 'HSPA2', 'MAPT']",0.6804900514181625,0,0,5
71,Angiogenesis WP1539,0.27443453398962897,3.293247767857143,4.258309453057827,['ANGPT1'],0.6804900514181625,0,0,1
72,Canonical and non-canonical Notch signaling WP3845,0.27443453398962897,3.293247767857143,4.258309453057827,['NOTCH2'],0.6804900514181625,0,0,1
73,Urea cycle and metabolism of amino groups WP497,0.27443453398962897,3.293247767857143,4.258309453057827,['ODC1'],0.6804900514181625,0,0,1
74,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.27443453398962897,3.293247767857143,4.258309453057827,['MRAS'],0.6804900514181625,0,0,1
75,One-carbon metabolism WP241,0.27443453398962897,3.293247767857143,4.258309453057827,['CHDH'],0.6804900514181625,0,0,1
76,Zinc homeostasis WP3529,0.28800832503065893,3.099264705882353,3.8578589989744003,['SLC39A11'],0.6804900514181625,0,0,1
77,Differentiation Pathway WP2848,0.28800832503065893,3.099264705882353,3.8578589989744003,['ALK'],0.6804900514181625,0,0,1
78,Breast cancer pathway WP4262,0.29227425259213297,1.6162437948152233,1.988081200128845,"['NOTCH2', 'FZD3', 'WNT7A']",0.6804900514181625,0,0,3
79,Neural Crest Differentiation WP2064,0.2952715117369007,1.883888532991672,2.2980802039920847,"['NOTCH2', 'FZD3']",0.6804900514181625,0,0,2
80,7-oxo-C and 7beta-HC pathways WP5064,0.30132928643380197,2.9268353174603177,3.5108900972389137,['ACOT11'],0.6804900514181625,0,0,1
81,TYROBP causal network in microglia WP3945,0.30132928643380197,2.9268353174603177,3.5108900972389137,['ADAP2'],0.6804900514181625,0,0,1
82,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.30132928643380197,2.9268353174603177,3.5108900972389137,['H2AFY2'],0.6804900514181625,0,0,1
83,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.30132928643380197,2.9268353174603177,3.5108900972389137,['GLI1'],0.6804900514181625,0,0,1
84,Hippo-Yap signaling pathway WP4537,0.30132928643380197,2.9268353174603177,3.5108900972389137,['TEAD1'],0.6804900514181625,0,0,1
85,Pre-implantation embryo WP3527,0.30132928643380197,2.9268353174603177,3.5108900972389137,['H2AFY2'],0.6804900514181625,0,0,1
86,Prostaglandin Synthesis and Regulation WP98,0.30132928643380197,2.9268353174603177,3.5108900972389137,['PTGDS'],0.6804900514181625,0,0,1
87,Head and Neck Squamous Cell Carcinoma WP4674,0.30219848231210256,1.8506805129415467,2.2146561651538734,"['NOTCH2', 'SESN1']",0.6804900514181625,0,0,2
88,Retinoblastoma gene in cancer WP2446,0.32290149967612675,1.7576980568011957,1.98691586911385,"['PRKDC', 'HMGB2']",0.6804900514181625,0,0,2
89,TLR4 Signaling and Tolerance WP3851,0.3272313883659627,2.633705357142857,2.9420799879937474,['INPP5D'],0.6804900514181625,0,0,1
90,Tryptophan metabolism WP465,0.3272313883659627,2.633705357142857,2.9420799879937474,['ALDH1A1'],0.6804900514181625,0,0,1
91,Fluoropyrimidine Activity WP1601,0.3272313883659627,2.633705357142857,2.9420799879937474,['UPP2'],0.6804900514181625,0,0,1
92,DNA IR-damage and cellular response via ATR WP4016,0.32977021426964215,1.728736308167316,1.9177895061615773,"['PRKDC', 'PPM1D']",0.6804900514181625,0,0,2
93,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.33837323918198275,1.4791614043950492,1.6028277805099944,"['RPS6KA3', 'MAP4K5', 'RHOQ']",0.6804900514181625,0,0,3
94,Vitamin A and carotenoid metabolism WP716,0.33982164805275583,2.508078231292517,2.7070550215176703,['ALDH1A1'],0.6804900514181625,0,0,1
95,Ethanol effects on histone modifications WP3996,0.33982164805275583,2.508078231292517,2.7070550215176703,['ALDH1A1'],0.6804900514181625,0,0,1
96,Hematopoietic Stem Cell Differentiation WP2849,0.33982164805275583,2.508078231292517,2.7070550215176703,['MXI1'],0.6804900514181625,0,0,1
97,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.33982164805275583,2.508078231292517,2.7070550215176703,['CARD8'],0.6804900514181625,0,0,1
98,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.33982164805275583,2.508078231292517,2.7070550215176703,['TEAD1'],0.6804900514181625,0,0,1
99,Alzheimer's disease WP2059,0.35025497868265276,1.6472813901345291,1.7281528237296282,"['CAPN2', 'MAPT']",0.6804900514181625,0,0,2
100,MTHFR deficiency WP4288,0.35217731957959536,2.3938717532467533,2.498293591574428,['CHDH'],0.6804900514181625,0,0,1
101,Amino Acid metabolism WP3925,0.35703740594502203,1.6218006209037599,1.6703163390782882,"['ALDH1A1', 'ODC1']",0.6804900514181625,0,0,2
102,Pathways Regulating Hippo Signaling WP4540,0.35703740594502203,1.6218006209037599,1.6703163390782882,"['PDGFRB', 'TEAD1']",0.6804900514181625,0,0,2
103,Sphingolipid pathway WP1422,0.3643027547996224,2.2895962732919255,2.311965658870463,['PLPP1'],0.6804900514181625,0,0,1
104,Neovascularisation processes WP4331,0.3643027547996224,2.2895962732919255,2.311965658870463,['ANGPT1'],0.6804900514181625,0,0,1
105,Oxysterols derived from cholesterol WP4545,0.3643027547996224,2.2895962732919255,2.311965658870463,['ACOT11'],0.6804900514181625,0,0,1
106,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3643027547996224,2.2895962732919255,2.311965658870463,['ANGPT1'],0.6804900514181625,0,0,1
107,Resistin as a regulator of inflammation WP4481,0.3762022250495964,2.1940104166666665,2.144926997650092,['PLCE1'],0.6857162923402901,0,0,1
108,Wnt signaling pathway and pluripotency WP399,0.3772265006721357,1.5498549195462938,1.5109682450140627,"['FZD3', 'WNT7A']",0.6857162923402901,0,0,2
109,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.3838989558942144,1.5272632741925,1.4621650466466187,"['PDGFRB', 'MRAS']",0.6857162923402901,0,0,2
110,Pyrimidine metabolism WP4022,0.3838989558942144,1.5272632741925,1.4621650466466187,"['PNPT1', 'POLR1A']",0.6857162923402901,0,0,2
111,Melatonin metabolism and effects WP3298,0.3878799229399621,2.1060714285714286,1.994574878742642,['CRY2'],0.6857162923402901,0,0,1
112,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3878799229399621,2.1060714285714286,1.994574878742642,['CREB5'],0.6857162923402901,0,0,1
113,Nuclear receptors WP170,0.3993399635479343,2.024896978021978,1.8587383582362371,['RORA'],0.6883073651537774,0,0,1
114,Prion disease pathway WP3995,0.3993399635479343,2.024896978021978,1.8587383582362371,['CHD2'],0.6883073651537774,0,0,1
115,Wnt signaling WP428,0.410269936312396,1.443086184655077,1.2857031399442258,"['FZD3', 'WNT7A']",0.6883073651537774,0,0,2
116,Glycolysis and Gluconeogenesis WP534,0.4105863858936881,1.9497354497354498,1.7355939221204701,['PFKP'],0.6883073651537774,0,0,1
117,ATM Signaling Pathway WP2516,0.4216231544678971,1.8799426020408163,1.623599950694517,['AP3B2'],0.6883073651537774,0,0,1
118,Tumor suppressor activity of SMARCB1 WP4204,0.4216231544678971,1.8799426020408163,1.623599950694517,['GLI1'],0.6883073651537774,0,0,1
119,Development of ureteric collection system WP5053,0.4216231544678971,1.8799426020408163,1.623599950694517,['GLI1'],0.6883073651537774,0,0,1
120,miRNA regulation of prostate cancer signaling pathways WP3981,0.4216231544678971,1.8799426020408163,1.623599950694517,['PDGFRB'],0.6883073651537774,0,0,1
121,PDGFR-beta pathway WP3972,0.4216231544678971,1.8799426020408163,1.623599950694517,['PDGFRB'],0.6883073651537774,0,0,1
122,Type 2 papillary renal cell carcinoma WP4241,0.4324541604792294,1.8149630541871922,1.5214453152917078,['COL21A1'],0.6883073651537774,0,0,1
123,DNA Replication WP466,0.4324541604792294,1.8149630541871922,1.5214453152917078,['ORC3'],0.6883073651537774,0,0,1
124,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4535140913311288,1.6975806451612903,1.3423261398938904,['RPS6KA3'],0.6883073651537774,0,0,1
125,IL-5 signaling pathway WP127,0.4535140913311288,1.6975806451612903,1.3423261398938904,['MAPT'],0.6883073651537774,0,0,1
126,p38 MAPK Signaling Pathway WP400,0.4535140913311288,1.6975806451612903,1.3423261398938904,['HMGN1'],0.6883073651537774,0,0,1
127,7q11.23 copy number variation syndrome WP4932,0.455033738900923,1.316031390134529,1.0362216802167883,"['HSPA2', 'DEK']",0.6883073651537774,0,0,2
128,Fas ligand pathway and stress induction of heat shock proteins WP314,0.463750444303154,1.6443917410714286,1.263564931549708,['PRKDC'],0.6883073651537774,0,0,1
129,Ferroptosis WP4313,0.463750444303154,1.6443917410714286,1.263564931549708,['FTH1'],0.6883073651537774,0,0,1
130,IL-2 signaling pathway WP49,0.463750444303154,1.6443917410714286,1.263564931549708,['MAPT'],0.6883073651537774,0,0,1
131,Cell cycle WP179,0.4674660670494414,1.2837143169637975,0.9761729739656466,"['PRKDC', 'ORC3']",0.6883073651537774,0,0,2
132,Adipogenesis WP236,0.47361914727619114,1.268139823869469,0.9477465381904937,"['RORA', 'PLIN2']",0.6883073651537774,0,0,2
133,Copper homeostasis WP3286,0.47379589357768737,1.594426406926407,1.1910024918106188,['MAPT'],0.6883073651537774,0,0,1
134,G13 Signaling Pathway WP524,0.47379589357768737,1.594426406926407,1.1910024918106188,['IQGAP1'],0.6883073651537774,0,0,1
135,Nephrotic syndrome WP4758,0.47379589357768737,1.594426406926407,1.1910024918106188,['PLCE1'],0.6883073651537774,0,0,1
136,Focal Adhesion WP306,0.4782402782025794,1.1695695695695696,0.8627236349452257,"['PDGFRB', 'CAPN2', 'ITGA7']",0.6883073651537774,0,0,3
137,Thermogenesis WP4321,0.47972937571323887,1.252936152039291,0.920323119302472,"['RPS6KA3', 'CREB5']",0.6883073651537774,0,0,2
138,Cytoplasmic Ribosomal Proteins WP477,0.47972937571323887,1.252936152039291,0.920323119302472,"['RPS6KA3', 'RPL23A']",0.6883073651537774,0,0,2
139,"GPCRs, Class A Rhodopsin-like WP455",0.48365398383183006,1.5474002100840336,1.1240091331337367,['ADORA1'],0.6889459625805925,0,0,1
140,Notch Signaling WP268,0.49332819418341217,1.5030612244897958,1.062033929105469,['NOTCH2'],0.6925990979850263,0,0,1
141,PDGF Pathway WP2526,0.49332819418341217,1.5030612244897958,1.062033929105469,['PDGFRB'],0.6925990979850263,0,0,1
142,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5121385712332747,1.421573359073359,0.9512600909678608,['SLC38A2'],0.6925990979850263,0,0,1
143,Endochondral Ossification WP474,0.5121385712332747,1.421573359073359,0.9512600909678608,['SLC38A2'],0.6925990979850263,0,0,1
144,IL-3 signaling pathway WP286,0.5121385712332747,1.421573359073359,0.9512600909678608,['INPP5D'],0.6925990979850263,0,0,1
145,Netrin-UNC5B signaling pathway WP4747,0.5121385712332747,1.421573359073359,0.9512600909678608,['INPP5D'],0.6925990979850263,0,0,1
146,One-carbon metabolism and related pathways WP3940,0.5121385712332747,1.421573359073359,0.9512600909678608,['CHDH'],0.6925990979850263,0,0,1
147,Ebola Virus Pathway on Host WP4217,0.515462411176301,1.168809167912307,0.7745591940325935,"['GSN', 'IQGAP1']",0.6925990979850263,0,0,2
148,Regulation of Microtubule Cytoskeleton WP2038,0.5212813793837398,1.384046052631579,0.9016579871673159,['MAPT'],0.6925990979850263,0,0,1
149,Eukaryotic Transcription Initiation WP405,0.530253592740886,1.3484432234432235,0.8554522595923959,['POLR1A'],0.6925990979850263,0,0,1
150,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5327133292990117,1.1308163363710884,0.7121562885028548,"['DEAF1', 'RORA']",0.6925990979850263,0,0,2
151,Ciliopathies WP4803,0.5474861220231803,1.0512612612612613,0.6332988804866373,"['EFHC1', 'PKD1L1', 'TOPORS']",0.6925990979850263,0,0,3
152,Energy Metabolism WP1541,0.5476988530311587,1.2824477351916377,0.7720716013653534,['NRF1'],0.6925990979850263,0,0,1
153,Exercise-induced Circadian Regulation WP410,0.5476988530311587,1.2824477351916377,0.7720716013653534,['CRY2'],0.6925990979850263,0,0,1
154,G1 to S cell cycle control WP45,0.5476988530311587,1.2824477351916377,0.7720716013653534,['ORC3'],0.6925990979850263,0,0,1
155,Mesodermal commitment pathway WP2857,0.5495422907614109,1.0951980568011959,0.6556617232708319,"['SESN1', 'TEAD1']",0.6925990979850263,0,0,2
156,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5561780635334302,1.2518069727891157,0.7343935632158514,['CTNNA1'],0.6925990979850263,0,0,1
157,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5561780635334302,1.2518069727891157,0.7343935632158514,['SYNGAP1'],0.6925990979850263,0,0,1
158,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5561780635334302,1.2518069727891157,0.7343935632158514,['PRKDC'],0.6925990979850263,0,0,1
159,IL-4 signaling pathway WP395,0.5561780635334302,1.2518069727891157,0.7343935632158514,['INPP5D'],0.6925990979850263,0,0,1
160,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5726646289870003,1.1947037337662338,0.6659935977937824,['DDX17'],0.7086724783714129,0,0,1
161,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5806778117003183,1.1680555555555556,0.6349073630830975,['NAP1L1'],0.7141255075569133,0,0,1
162,Mitochondrial complex I assembly model OXPHOS system WP4324,0.6112620497460846,1.0723396501457727,0.5278372367385817,['NDUFAF2'],0.7326386069966238,0,0,1
163,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6112620497460846,1.0723396501457727,0.5278372367385817,['PLCE1'],0.7326386069966238,0,0,1
164,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6112620497460846,1.0723396501457727,0.5278372367385817,['PDGFRB'],0.7326386069966238,0,0,1
165,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6185545085554313,1.0508035714285715,0.5047744704047321,['FZD3'],0.7326386069966238,0,0,1
166,p53 transcriptional gene network WP4963,0.6185545085554313,1.0508035714285715,0.5047744704047321,['SESN1'],0.7326386069966238,0,0,1
167,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6185545085554313,1.0508035714285715,0.5047744704047321,['PLCE1'],0.7326386069966238,0,0,1
168,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6257107617973338,1.030112044817927,0.4829856023329484,['ANGPT1'],0.7326386069966238,0,0,1
169,3q29 copy number variation syndrome WP4906,0.6327333424061751,1.0102163461538463,0.46238229064805464,['PIGM'],0.7326386069966238,0,0,1
170,AMP-activated protein kinase (AMPK) signaling WP1403,0.6327333424061751,1.0102163461538463,0.46238229064805464,['SLC2A4RG'],0.7326386069966238,0,0,1
171,MET in type 1 papillary renal cell carcinoma WP4205,0.6327333424061751,1.0102163461538463,0.46238229064805464,['ALK'],0.7326386069966238,0,0,1
172,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6595359717899414,0.9377391581632653,0.3903046336267156,['HSPA2'],0.7534483481578029,0,0,1
173,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6634253910781925,0.8925124533001245,0.36623255961725765,"['CAPN2', 'CTNNA1', 'PDE4DIP', 'LARP7', 'NAP1L1', 'IQGAP1']",0.7534483481578029,0,0,6
174,Integrated breast cancer pathway WP1984,0.6642151980760593,0.8817876926555376,0.360782630722234,"['RASGEF1A', 'ODC1']",0.7534483481578029,0,0,2
175,Endometrial cancer WP4155,0.6659265703414925,0.9212092731829574,0.37454146101726943,['CTNNA1'],0.7534483481578029,0,0,1
176,Non-small cell lung cancer WP4255,0.6903166747890808,0.8605093676814989,0.3189089345541081,['ALK'],0.7743490053385339,0,0,1
177,16p11.2 proximal deletion syndrome WP4949,0.6961319340922173,0.8465581797235023,0.3066369820791903,['PPP4R4'],0.7743490053385339,0,0,1
178,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6961319340922173,0.8465581797235023,0.3066369820791903,['MAP4K5'],0.7743490053385339,0,0,1
179,Vitamin D Receptor Pathway WP2877,0.7018384695697266,0.8330498866213152,0.2949429799254613,['CD9'],0.776335290362044,0,0,1
180,Ciliary landscape WP4352,0.719467502551751,0.8055440055440055,0.2652204664282045,"['ARMC8', 'IQGAP1', 'EFHC2']",0.7872319983686659,0,0,3
181,Corticotropin-releasing hormone signaling pathway WP2355,0.7236172914297838,0.7830490405117271,0.2533105930280894,['GRK3'],0.7872319983686659,0,0,1
182,Glioblastoma signaling pathways WP2261,0.7236172914297838,0.7830490405117271,0.2533105930280894,['PDGFRB'],0.7872319983686659,0,0,1
183,Spinal Cord Injury WP2431,0.7288098253246467,0.7714679621848739,0.24404806650156916,['VCAN'],0.7885483355971588,0,0,1
184,B Cell Receptor Signaling Pathway WP23,0.7339052294589924,0.7602225672877847,0.23519414098833535,['INPP5D'],0.7897458447439156,0,0,1
185,Senescence and Autophagy in Cancer WP615,0.7486265849631064,0.7283606150793651,0.21087130252278263,['GSN'],0.7969250743155648,0,0,1
186,Pancreatic adenocarcinoma pathway WP4263,0.7486265849631064,0.7283606150793651,0.21087130252278263,['ARHGEF6'],0.7969250743155648,0,0,1
187,Male infertility WP4673,0.7625369137395152,0.699047619047619,0.1895148575187236,['CHD2'],0.8073920263124278,0,0,1
188,Androgen receptor signaling pathway WP138,0.7670012231790184,0.6897908834586466,0.1829786774793769,['PLPP1'],0.8077991605821576,0,0,1
189,DNA damage response (only ATM dependent) WP710,0.7798989694150461,0.6634267631103075,0.1649218521973515,['WNT7A'],0.8170370155776674,0,0,1
190,Endoderm differentiation WP2853,0.8406476582636869,0.5451543898809523,0.094629350461936,['SESN1'],0.8760433491379473,0,0,1
191,DNA Repair Pathways Full Network WP4946,0.8605095644689392,0.5078016643550625,0.07628732250384038,['PRKDC'],0.8861502258378366,0,0,1
192,Calcium Regulation in the Cardiac Cell WP536,0.8657173585859197,0.49804421768707485,0.07181638217938843,['STIM2'],0.8861502258378366,0,0,1
193,TGF-beta Signaling Pathway WP366,0.8682482010734359,0.49330357142857145,0.06969277387572904,['NEDD4L'],0.8861502258378366,0,0,1
194,Ectoderm Differentiation WP2858,0.8682482010734359,0.49330357142857145,0.06969277387572904,['HMGB2'],0.8861502258378366,0,0,1
195,Fragile X Syndrome  WP4549,0.8755593099051653,0.4796035386631717,0.06373565835336416,['SYNGAP1'],0.8890294531344755,0,0,1
196,Hepatitis B infection WP4666,0.8846828757559053,0.462468394437421,0.05666441668066852,['CREB5'],0.8937102520391288,0,0,1
197,mRNA Processing WP411,0.9046823087770588,0.4245063879210221,0.042523414866786194,['SREK1'],0.9092746047606987,0,0,1
198,IL-18 signaling pathway WP4754,0.9603938893894445,0.3077451394759087,0.012436528018127262,['DEK'],0.9603938893894445,0,0,1
